$19.13 $0.31 per serving
Product analysis
Ginkgo+ combines ginkgo and bacopa for attention and memory support, but benefits remain uncertain because the exact extracts matter.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Named plant compounds provide some identity detail without establishing extract quality. The exact preparations matter, so results from particular extracts may not apply.
Ingredient Transparency80
Amounts and named plant compounds help identify what is declared. The ginkgo component breakdown remains unclear, limiting a closer preparation comparison.
Value For Money61
The serving is economical when judged for bacopa. Value for the ginkgo and ginseng portions remains uncertain.
Customer Satisfaction71
Customer ratings are positive. The small pool of 87 ratings gives a limited picture of buyer satisfaction.
Product Focus58
Ginkgo and bacopa give the formula an attention and memory focus. Their preparation-dependent findings do not establish a dependable everyday productivity benefit.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.31
- Customer rating
- 4.7 · 87 ratings
Goals
Impact
Moderate effect
Bacopa · 200 mg
Ginkgo and bacopa address different aspects of cognition: selected attention tasks and memory or learning after repeated use. Both preparations are unidentified here, which limits transfer of results from named extracts; the 200 mg bacopa amount also provides only partial exposure support in the saved findings.
How this product is rated for Cognitive Support
Ingredient fit83
The relevant ingredients are closely focused on cognitive support, although the product is also linked to other goals. The relevant amounts provide substantial but incomplete exposure support.
Goal fit
The relevant ingredients are closely focused on cognitive support, although the product is also linked to other goals.
Dose adequacy
The relevant amounts provide substantial but incomplete exposure support.
Pathways40
Cerebral blood flow is the strongest supported mechanism, with moderate coverage. One cognitive mechanism reaches the saved coverage target; support across other mechanisms is limited.
Depth
Cerebral blood flow is the strongest supported mechanism, with moderate coverage.
Breadth
One cognitive mechanism reaches the saved coverage target; support across other mechanisms is limited.
Evidence27
Bacopa provides the strongest evidence contribution among the ingredients counted at a sufficient amount. Its support remains specific to the supplied cognitive findings. The counted botanical preparations are not matched to the studied preparations.
Evidence strength
Bacopa provides the strongest evidence contribution among the ingredients counted at a sufficient amount. Its support remains specific to the supplied cognitive findings.
Studied preparation
The counted botanical preparations are not matched to the studied preparations.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 2 of 2 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
2 of 2 counted ingredients meet the saved minimum exposure threshold.
Impact
Moderate effect
Bacopa · 200 mg
Bacopa is relevant to memory and learning, with benefits depending on the extract and sustained use. The serving contains 200 mg of an extract standardized to 20% bacosides, while ginkgo contributes 125 mg; routine cognitive benefits from ginkgo remain uncertain. Ginseng findings are mixed and preparation-specific.
How this product is rated for Brain Health
Ingredient fit86
Ginkgo and bacopa give the formula a clear brain-health connection, with differing amount coverage.
Goal fit
The relevant actives are focused on this goal.
Dose adequacy
Ginkgo and bacopa together provide substantial but incomplete coverage of the saved dose comparisons.
Pathways43
The saved assessment is strongest for brain energy processes, with smaller contributions elsewhere.
Depth
Brain energy metabolism is the strongest area; oxidative protection and acetylcholine signalling are less covered.
Breadth
Only brain energy metabolism has substantial coverage.
Evidence43
Evidence is mixed, and the bacopa preparation remains a limitation.
Evidence strength
Ginkgo supplies the strongest saved evidence contribution, though routine cognitive benefits remain uncertain.
Studied preparation
The saved preparation check is partly met; bacopa is not matched to a studied extract.
Formulation logic100
Both relevant ingredients meet the minimum amount comparison without a flagged conflict.
Partner coverage
No required partner is missing for the relevant ingredients.
Conflicts
No configured ingredient conflict was found.
Effective doses
Both ginkgo and bacopa meet the saved minimum amount comparison.
Impact
Moderate effect
Ginkgo has mixed attention findings, while bacopa has limited, preparation-specific acute cognitive evidence. The 200 mg bacopa amount cannot be assumed to match a named studied extract, so the expected focus contribution remains modest.
How this product is rated for Mental Focus
Ingredient fit85
The saved assessment finds a concentrated set of ingredients relevant to focus. The assessed amounts provide partial support against the saved dose references (79.3 out of 100).
Goal fit
The saved assessment finds a concentrated set of ingredients relevant to focus.
Dose adequacy
The assessed amounts provide partial support against the saved dose references (79.3 out of 100).
Pathways44
The strongest saved coverage concerns cerebral energy supply, with partial coverage. One mechanism reaches the saved coverage threshold, so support is concentrated in one aspect of focus.
Depth
The strongest saved coverage concerns cerebral energy supply, with partial coverage.
Breadth
One mechanism reaches the saved coverage threshold, so support is concentrated in one aspect of focus.
Evidence50
Ginkgo leads the saved evidence comparison at an assessed amount. Some qualifying ingredients do not match the saved studied-preparation category: Bacopa.
Evidence strength
Ginkgo leads the saved evidence comparison at an assessed amount.
Studied preparation
Some qualifying ingredients do not match the saved studied-preparation category: Bacopa.
Formulation logic100
The assessed ingredients work independently or have their listed partner. No ingredient conflict is recorded in the saved assessment.
Partner coverage
The assessed ingredients work independently or have their listed partner.
Conflicts
No ingredient conflict is recorded in the saved assessment.
Effective doses
All assessed ingredients reach the saved minimum dose threshold.
Impact
Moderate effect
Ginkgo at 125 mg and bacopa at 200 mg provide limited links to cognitive tasks relevant to productivity. Bacopa evidence concerns specific extracts after repeated use, and its declared preparation is not matched to the reviewed material. Ginseng findings are mixed and preparation-specific, so it adds no independent contribution here.
How this product is rated for Productivity Boost
Ingredient fit88
The relevant actives are focused on cognitive or fatigue-related support. The assessed amounts provide partial coverage of the saved dose comparison; unknown individual quantities limit the assessment where present.
Goal fit
The relevant actives are focused on cognitive or fatigue-related support.
Dose adequacy
The assessed amounts provide partial coverage of the saved dose comparison; unknown individual quantities limit the assessment where present.
Pathways15
The strongest saved contribution concerns maintenance of nerve connections and protection of brain cells, with limited coverage. No assessed process reaches the saved coverage threshold.
Depth
The strongest saved contribution concerns maintenance of nerve connections and protection of brain cells, with limited coverage.
Breadth
No assessed process reaches the saved coverage threshold.
Evidence41
Ginkgo supplies the strongest saved evidence contribution at the assessed amount. Evidence for cognitive tasks or nutrient roles does not establish work output. The saved preparation match is limited for Bacopa; the remaining assessed ingredients have accepted matches.
Evidence strength
Ginkgo supplies the strongest saved evidence contribution at the assessed amount. Evidence for cognitive tasks or nutrient roles does not establish work output.
Studied preparation
The saved preparation match is limited for Bacopa; the remaining assessed ingredients have accepted matches.
Formulation logic100
The assessed ingredients can contribute alone or have their required companion present. No opposing ingredient effect was identified by the saved checks. All ingredients included in the saved dose check reach its minimum threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required companion present.
Conflicts
No opposing ingredient effect was identified by the saved checks.
Effective doses
All ingredients included in the saved dose check reach its minimum threshold.
Impact
Moderate effect
Whether ginkgo improves everyday vision is unclear. Its connection to circulation in the eye concerns specific extracts and eye conditions, which doesn't translate reliably to routine use. The declared amount alone doesn't show that you'll see more clearly.
How this product is rated for Eye Health
Ingredient fit55
Ginkgo has an uncertain role in routine vision; results for specific eye conditions don't transfer reliably to everyday use.
Goal fit
Eye-related nutrients sit alongside ingredients intended for other purposes; a broad ingredient list doesn't imply broader visual benefits.
Dose adequacy
Ginkgo 125 mg per selected serving; these amounts aren't guarantees of better vision.
Pathways43
The relevant connection is circulation in the eye, but improved everyday vision remains uncertain.
Depth
The relevant connection is circulation in the eye, but improved everyday vision remains uncertain.
Breadth
The eye-related connection is narrow; the ingredients don't imply broad improvements across different aspects of vision.
Evidence64
Ginkgo has an uncertain role in routine vision; results for specific eye conditions don't transfer reliably to everyday use.
Evidence strength
Ginkgo has an uncertain role in routine vision; results for specific eye conditions don't transfer reliably to everyday use.
Studied preparation
Specific ginkgo extracts and eye conditions limit how confidently benefits can be applied to routine use.
Formulation logic100
No particular ingredient conflict or missing required partner is identified. Ingredient amounts and combinations still don't guarantee a visual benefit.
Partner coverage
No required ingredient partner is identified as missing for the ingredients considered here.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The known amounts permit dose comparisons, but reference amounts aren't guarantees of a noticeable vision benefit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Panax ginseng Root Extract (Ginsenosides) | 200 mg | |
Bacopa monnieri Whole Plant Extract (Bacosides) | 200 mg | |
Ginkgo biloba Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 125 mg |
Ginkgo leaf extract is individually listed at 125 mg per serving with 24% flavones and 6% terpenes, making its composition easier to compare. A qualifying ginkgolic acid limit declaration is unavailable in the saved facts, so those marker percentages do not establish that separate detail.
How this ingredient is rated
Composition and Label Disclosure70
Both marker percentages are recorded, giving a clearer description of the extract’s composition. A qualifying ginkgolic acid limit declaration is unavailable; marker disclosure alone does not resolve it.
Marker and Preparation Disclosure
The extract lists 24% flavones and 6% terpenes, providing explicit composition markers for comparison.
Declared Ginkgolic Acid Limit
The saved facts contain no qualifying ginkgolic acid limit declaration; they do not establish its actual concentration.
Composition and Label Disclosure100
The 125 mg leaf extract amount and preparation are individually disclosed per serving. The quantity is clear, although this assessment does not determine whether it is effective.
Individual Preparation Amount Disclosure
The individual listing identifies 125 mg of ginkgo leaf extract per serving, separating its preparation amount from other ingredients.
Commercial Price and Usability
No price comparison was included in this evaluation.
Bacopa (Bacosides) · 200 mg OverallScore100
The serving declares 200 mg of whole-plant bacopa extract with a stated 20% bacoside concentration. Both preparation mass and composition are available for comparison, at about $0.32 for the whole-product serving.
How this ingredient is rated
Composition and Label Disclosure
The saved facts identify whole-plant bacopa extract, while the supplied evaluation provides no separate conclusion about absorption or comparative form quality.
Composition and Label Disclosure100
The preparation amount and bacoside concentration are both recorded, making the ingredient’s composition clearer than mass alone. The percentage is a label claim rather than independent verification.
Amount and Label Disclosure
The serving amount of 200 mg and stated 20% bacoside concentration are both available; the preparation mass is distinct from bacoside mass.
Commercial Price and Usability100
The whole-product serving costs about $0.32. That price is not allocated to bacopa and does not establish equal bacoside content across different preparations.
Commercial Price per Labeled Serving
About $0.32 per labeled whole-product serving; this compares serving cost rather than the price of an equivalent bacopa or bacoside amount.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
- A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
- Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].